Evidence map›Paper›PMID 37497706›Full record

ReviewCurrent molecular medicine2024

Quorum Sensing in Gram-Negative Bacteria: Strategies to Overcome Antibiotic Resistance in Ocular Infections.

Sakshi Tiwari, Bina Gidwani, Amber Vyas

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current molecular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Sakshi TiwariUniversity Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, C.G., India.ORCID 0000-0001-7319-9557
Bina GidwaniColumbia Institute of Pharmacy, Raipur, C.G., India.ORCID 0000-0003-1257-723X
Amber VyasUniversity Institute of Pharmacy, Pt. Ravishankar Shukla University, Raipur, C.G., India.ORCID 0000-0002-2545-2869
Pandit Ravishankar Shukla University · INRaipur Municipal Corporation · IN

Funding

Department of Science and Technology, New Delhi, India DST/INSPIRE Fellowship/2019/IF190329, DST/NM/NT/2018/20DST-FIST SR/FST/COLLEGE/2018/418
6 · The paper itself

Abstract

Truly miraculous medications and antibiotics have helped save untold millions of lives. Antibiotic resistance, however, is a significant issue related to health that jeopardizes the effectiveness of antibiotics and could harm everyone's health. Bacteria, not humans or animals, become antibiotic-resistant. Bacteria use quorum-sensing communication routes to manage an assortment of physiological exercises. Quorum sensing is significant for appropriate biofilm development. Antibiotic resistance occurs when bacteria establish a biofilm on a surface, shielding them from the effects of infection-fighting drugs. Acylated homoserine lactones are used as autoinducers by gram-negative microscopic organisms to impart. However, antibiotic resistance among ocular pathogens is increasing worldwide. Bacteria are a significant contributor to ocular infections around the world. Gram-negative microscopic organisms are dangerous to ophthalmic tissues. This review highlights the use of elective drug targets and treatments, for example, combinational treatment, to vanquish antibiotic-resistant bacteria. Also, it briefly portrays anti-biotic resistance brought about by gram-negative bacteria and approaches to overcome resistance with the help of quorum sensing inhibitors and nanotechnology as a promising medication conveyance approach to give insurance of anti-microbials and improve pathways for the administration of inhibitors of quorum sensing with a blend of anti-microbials to explicit target destinations and penetration through biofilms for treatment of ocular infections. It centres on the methodologies to sidestep the confinements of ocular anti-biotic delivery with new visual innovation.

Indexed as

Anti-Bacterial AgentsGram-Negative BacteriaQuorum SensingAnimalsBiofilmsDrug Resistance, BacterialEye InfectionsGram-Negative Bacterial InfectionsHumansAnti-Bacterial Agentsantibiotic resistanceAntibioticsbiofilmgram-negative bacteria.ocular infectionsquorum sensingquorum sensing inhibitors

Identifiers

PMID37497706
OpenAlexW4385294961

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.